Summary
A medRxiv preprint reports that altered placental LBX1 was associated with spontaneous preterm birth in analyses of 70 placentae and 53 maternal plasma samples. Cell findings suggest a pathway involving nuclear import, ribosomal disruption and the unfolded protein response.
A medRxiv preprint reports a possible placental pathway associated with spontaneous preterm birth (sPTB), involving dysregulation of the transcription factor ladybird homeobox protein 1, or LBX1. The researchers link elevated LBX1 with disruption of ribosome-related processes in placental trophoblast cells and activation of the unfolded protein response, a cellular reaction to protein-folding stress.
The study used placental protein profiling and an independent analysis of maternal plasma. Its findings identify LBX1 as a candidate molecular link between placental dysfunction and spontaneous prematurity, but the work is still a preprint and has not undergone peer review.
Evidence from placenta and maternal circulation
The researchers used a cross-sectional design to profile 70 placentae from spontaneous term and preterm birth deliveries. They constructed protein co-expression networks, which map proteins whose levels vary together, and identified 13 hub proteins associated with sPTB. A hub protein is a network component whose relationships with many other proteins make it a potential indicator of a broader biological process.
The team then examined an independent nested case-control set containing 53 maternal plasma samples. LBX1 levels were elevated in maternal circulation from sPTB cases. This result connects the placental finding with a measurable protein in maternal blood, although the study presents it as a molecular association rather than a validated clinical prediction test.
Spontaneous preterm birth is a major pregnancy complication and, according to the preprint, affects approximately 9.9% of pregnancies worldwide. Placental dysfunction is known to be involved in some cases, but the signalling events linking placental changes to spontaneous early delivery remain incompletely defined. The study focuses on one such possible pathway.
How the proposed LBX1 mechanism works
Trophoblasts are specialised placental cells that help form and maintain the interface between the pregnant person and the developing fetus. In these cells, the authors report that elevated LBX1 undergoes KPNB1-mediated nuclear import. KPNB1 is a transport protein that helps move selected proteins into the cell nucleus, where gene regulation takes place.
Once in the nucleus, the study links increased LBX1 to deregulated ribosomal biogenesis. Ribosomes are the cellular structures that build proteins, while ribosomal biogenesis refers to the production and assembly of those structures. The reported disruption also perturbs ribosomal protein homeostasis—the balance needed to produce and manage ribosomal components.
According to the researchers, this disturbance contributes to the accumulation of newly synthesised proteins inside trophoblast cells. The buildup activates the unfolded protein response, a stress-response system that changes cellular protein production and handling when the protein-folding system is under strain. The authors propose that sustained activation of this pathway may contribute to adverse pregnancy outcomes and spontaneous preterm birth.
The work therefore joins three observations into a single biological model: higher LBX1 in sPTB-associated samples, LBX1 movement into trophoblast nuclei, and downstream ribosomal and protein-stress responses. If supported by further studies, this model could help researchers investigate whether placental protein-stress pathways are useful for earlier risk assessment or future interventions.
The human analyses were cross-sectional and nested case-control molecular comparisons, while the mechanistic observations came from trophoblast-cell experiments described by the authors. The preprint identifies a candidate mechanism and a possible circulating marker; clinical prediction, treatment, and effects of altering the LBX1 pathway require validation in subsequent research.